MAPT and Alzheimer disease: In the AD patient population, all NDEV markers except P-S396-tau followed a common pattern of progressive increase with dementia severity that was significant for total tau, NRGN, and REST, but not for Aß42 and P-T181-tau (Fig. 1a–c, e, f).